3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
10
Carcinoma, Non-Small-Cell Lung
10
Carcinoma, Hepatocellular
8
Lung Neoplasms
6
Colorectal Neoplasms
6
Neoplasms
5
Prostatic Neoplasms
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Ovarian Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Liver Neoplasms
2
Extensive Stage Lung Small Cell Carcinoma
2
Carcinoma, Renal Cell
2
Carcinoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaccinia
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Papillary renal cell carcinoma, sporadic
1
PIK3CA-Mutated Cancers
1
Osteosarcoma
1
Interventions
Temozolomide
6
Radiosurgery
6
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Specimen Handling
3
Nivolumab
3
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Receptors, Interleukin-8B
2
Radiation
2
Mental Status and Dementia Tests
2
Memantine
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
brivaracetam
1
binimetinib
1
Valacyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
atezolizumab
×
30 days
×
Clear all
No trials found.